Invention Grant
US08435569B2 Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
有权
包含至少一种溶栓剂（A）和至少一种选自一氧化二氮，氩，氙，氦，氖的气体（B）的药物组合物
- Patent Title: Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
- Patent Title (中): 包含至少一种溶栓剂（A）和至少一种选自一氧化二氮，氩，氙，氦，氖的气体（B）的药物组合物
-
Application No.: US12598225Application Date: 2008-04-30
-
Publication No.: US08435569B2Publication Date: 2013-05-07
- Inventor: Jacques H. Abraini
- Applicant: Jacques H. Abraini
- Applicant Address: CA Quebec
- Assignee: NNOXE Pharmaceutiques Inc.
- Current Assignee: NNOXE Pharmaceutiques Inc.
- Current Assignee Address: CA Quebec
- Agency: Foley & Lardner LLP
- Priority: EP07107219 20070430
- International Application: PCT/EP2008/055392 WO 20080430
- International Announcement: WO2008/132239 WO 20081106
- Main IPC: A01N59/00
- IPC: A01N59/00 ; A61K33/00
Abstract:
The present invention relates to a pharmaceutical composition comprising at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, as a combined composition for simultaneous, separate or sequential use for treating ischemia. The present invention also relates to the use of at least one thrombolytic agent (A), such as the human recombinant form of tissue-type plasminogen activator (rt-PA), and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon, and mixtures thereof, for the preparation of a combined pharmaceutical composition for treating ischemia.
Public/Granted literature
Information query
